BMRA Biomerica, Inc: Market Value to Book Value Ratio

Corporate emblem and logo of Biomerica (BMRA)

The market-to-book value trend on the GURU.Markets temporary chart demonstrates the position of Biomerica, Inc. (BMRA), which is protected by patents for home gastrointestinal tests. The 2.16 mark serves as the current indicator as the company scales retail sales of its diagnostics. The business's success is based on the qualifications of its biochemists, who foster a culture of scientific precision and high-quality research.

Biomerica Inc (BMRA) - Market-to-Book Ratio from 07/04/2022 to 10/30/2026
Flagship merchandise of Biomerica, Inc

This indicator determines the market value of assets relative to their book value, measuring the premium for future growth. For Biomerica, Inc. (BMRA), with its outsourcing model for production and IT infrastructure, this ratio reflects the value of intangible advantages. By analyzing the market cap to book capitalization multiple, an investor can track the dynamics of market confidence in the business model. A decline in this metric signals either undervaluation or a systemic crisis.

Competitor analysis

A: Market Capitalization to Book Value Ratio|questdiagnostics.com (DGX) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Illumina|Market Cap to Net Assets Ratio Exact Sciences Corp (EXAS)|Market Capitalization to Book Value Ratio RVTY|BIO - Market-to-Book Ratio|Market Capitalization to Book Value Ratio NNNN (Anbio Biotechnology)|SHC: Capitalization to Book Value Ratio|QuidelOrtho Corporation - Market Capitalization to Book Value Ratio|OPK - Market Capitalization to Book Value Ratio|CareDx (CDNA) - Market Value to Book Value Ratio|Capitalization to Book Value Ratio MRVI|FLGT (Fulgent Genetics, Inc.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio fluidigm.com|Market Value to Book Value Ratio Cytek Biosciences (CTKB)|Market Value to Book Value Ratio OSUR (OraSure Technologies, Inc.)|Exagen - Market Cap to Net Assets Ratio|MDxHealth, Inc. (MDXH) - Market-to-Book Ratio|LUCD - Market Value to Book Value Ratio|Market Capitalization to Book Value Prenetics Global PRE|IMDX: Market Capitalization to Book Value Ratio|TRIB - Market Capitalization to Book Value|Market Value to Book Value Ratio ProPhase|Ainos Corporation (AIMD) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio CODX|Market Value to Book Value Ratio HSCS (heartsciences.com)|Market Capitalization to Book Value Ratio CDIO (Cardio Diagnostics Holdings)|Market Capitalization to Book Value Virax Biolabs Group Limited (VRAX)|BJDX - Market Value to Book Value Ratio|Market-to-Book Ratio Aspira Women's Health Inc|Accelerate Diagnostics (AXDX) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio CENTOGENE|ENZ (Enzo Biochem Inc.) - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Fresh2 FRES|Market Value to Book Value Ratio Genetic Technologies (GENE)|ME (23andMe Inc) - Market Value to Book Value|Market Capitalization to Book Value Ratio PMD (Psychemedics)